CMV Diagnosis in Immunocompromised Patients

Diagnostic Methods

The Centers for Disease Control and Prevention recommends quantitative PCR as the preferred diagnostic method for detecting active CMV infection in immunocompromised patients, due to its high sensitivity (82-100%) and specificity (86-100%) 1
The American Society of Transplantation suggests that quantitative PCR offers rapid results with the ability to quantify viral burden, which guides treatment decisions 4, 5
The Infectious Diseases Society of America notes that PCR can detect CMV during neutropenia when other tests like pp65 antigenemia fail due to low leukocyte counts 6

The Centers for Disease Control and Prevention states that serology (including IgM) has severely limited diagnostic value in immunocompromised patients due to high false-positive rates and poor sensitivity (50.8% pooled sensitivity for detecting active CMV colitis) 3, 7
The American College of Gastroenterology notes that serology cannot distinguish active from latent infection, as over 90% of adults have positive CMV IgG from past exposure 7

The Centers for Disease Control and Prevention recommends ordering quantitative CMV DNA PCR from blood as the first-line test for diagnosing CMV in immunocompromised patients 2, 5, 6
The American Society of Transplantation suggests that CMV encephalitis can be diagnosed using CSF PCR (sensitivity 82-100%, specificity 86-100%) 1
The Infectious Diseases Society of America notes that CMV pneumonitis can be diagnosed using BAL fluid PCR plus serum PCR (negative BAL effectively rules out CMV pneumonia with >99% NPV) 8

The American Society of Transplantation recommends monthly quantitative PCR monitoring for the first year post-transplant for all at-risk patients (except CMV donor-negative/recipient-negative) 5, 6
The Infectious Diseases Society of America suggests that preemptive therapy should be initiated when CMV viremia is detected or when ≥2 consecutive PCR tests are positive 7

The Centers for Disease Control and Prevention warns that relying on serology alone in immunocompromised patients is insufficient - viral load testing or tissue diagnosis is essential 3, 7
The American College of Gastroenterology notes that assuming negative IgM rules out CMV is incorrect - PCR is required for diagnosis 7
The Infectious Diseases Society of America advises against ordering CMV culture for rapid diagnosis due to its poor sensitivity and slow turnaround time compared to PCR 2, 7